Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention

MLA

Li-Wen Li, et al. “Plasma MiR-126 as a Potential Marker Predicting Major Adverse Cardiac Events in Dual Antiplatelet-Treated Patients after Percutaneous Coronary Intervention.” EuroIntervention, vol. 9, Sept. 2013, pp. 546–54. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....197d3ca18a4512a07e502ad83fada6be&authtype=sso&custid=ns315887.

APA

Li-Wen Li, Xi-Yong Yu, Ji-Yan Chen, Zhi-Wei Zheng, Hong Wu, Ya-ling Han, Zhi-Wei Zhang, Shi-Long Zhong, Qiu-Xiong Lin, & Zhi-Hong Chen. (2013). Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention. EuroIntervention, 9, 546–554.

Chicago

Li-Wen Li, Xi-Yong Yu, Ji-Yan Chen, Zhi-Wei Zheng, Hong Wu, Ya-ling Han, Zhi-Wei Zhang, Shi-Long Zhong, Qiu-Xiong Lin, and Zhi-Hong Chen. 2013. “Plasma MiR-126 as a Potential Marker Predicting Major Adverse Cardiac Events in Dual Antiplatelet-Treated Patients after Percutaneous Coronary Intervention.” EuroIntervention 9 (September): 546–54. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....197d3ca18a4512a07e502ad83fada6be&authtype=sso&custid=ns315887.